Published in Hematology Week, May 30th, 2005
AAIsafeR 2 is ELA Medical's second-generation pacing mode that prevents unnecessary ventricular pacing, and is the first therapeutic-pacing alternative available in the United States.
Several recent clinical studies show that unnecessary right ventricular pacing increases a patient's risk of developing heart failure and atrial fibrillation. ELA Medical's Symphony pacemakers, with AAIsafeR 2 mode, limit unnecessary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week